-
TCRR Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
-
ETFs
- Insider
- Institutional
- Shorts
Tcr2 Therapeutics (TCRR)
Company Profile
Quarter (USD) | Mar 23 | Dec 22 | Sep 22 | Jun 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 15.60 mm | 15.60 mm | 15.60 mm | 15.60 mm | 15.60 mm | 15.60 mm |
Cash burn (monthly) | 6.10 mm | 4.97 mm | 13.84 mm | 13.82 mm | 13.34 mm | 9.19 mm |
Cash used (since last report) | 126.78 mm | 103.36 mm | 287.56 mm | 287.17 mm | 277.19 mm | 191.10 mm |
Cash remaining | -111.18 mm | -87.76 mm | -271.96 mm | -271.57 mm | -261.59 mm | -175.51 mm |
Runway (months of cash) | -18.2 | -17.6 | -19.7 | -19.7 | -19.6 | -19.1 |
13F holders | Current |
---|---|
Total holders | 58 |
Opened positions | 7 |
Closed positions | 14 |
Increased positions | 12 |
Reduced positions | 16 |
13F shares | Current |
---|---|
Total value | 28.14 bn |
Total shares | 24.96 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
MPM Asset Management | 4.05 mm | $6.08 bn |
Tang Capital Management | 3.40 mm | $5.10 bn |
MPM Oncology Impact Management | 3.37 mm | $5.06 bn |
Tang Capital Partners | 2.74 mm | $0.00 |
Vanguard | 1.47 mm | $2.20 bn |
Upnorth Investment | 1.28 mm | $39.63 mm |
Newtyn Management | 1.02 mm | $1.52 bn |
Acadian Asset Management | 812.46 k | $1.22 mm |
BLK BlackRock | 789.91 k | $1.18 bn |
Baker Bros. Advisors | 753.06 k | $1.13 bn |